Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Vaxart is a biotechnology business based in the US. Vaxart stocks (VXRT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.76 – an increase of 1.71% over the previous week. Vaxart employs 164 staff and has a trailing 12-month revenue of around $107,000.
Finder Award
Interactive Brokers
National Bank Direct Brokerage
| Latest market close | $0.76 |
|---|---|
| 52-week range | $0.70 - $5.32 |
| 50-day moving average | $0.95 |
| 200-day moving average | $2.11 |
| Wall St. target price | $6.13 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.81 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $0.76 from 2023-03-27
| 1 week (2023-03-22) | 2.77% |
|---|---|
| 1 month (2023-03-01) | -1.87% |
| 3 months (2022-12-29) | -19.95% |
| 6 months (2022-09-29) | -64.32% |
| 1 year (2022-03-28) | -85.07% |
|---|---|
| 2 years (2021-03-29) | -86.52% |
| 3 years (2020-03-27) | 1.74 |
| 5 years (2018-03-29) | 5.3138 |
| Revenue TTM | $107,000 |
|---|---|
| Gross profit TTM | $-9,076,000 |
| Return on assets TTM | -36.78% |
| Return on equity TTM | -72.29% |
| Profit margin | 0% |
| Book value | $0.82 |
| Market capitalisation | $100.2 million |
TTM: trailing 12 months
We're not expecting Vaxart to pay a dividend over the next 12 months.
Vaxart's shares were split on a 1:11 basis on 14 February 2018. So if you had owned 11 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Vaxart shares – just the quantity. However, indirectly, the new 1000% higher share price could have impacted the market appetite for Vaxart shares which in turn could have impacted Vaxart's share price.
Over the last 12 months, Vaxart's shares have ranged in value from as little as $0.7 up to $5.32. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vaxart's is 0.8285. This would suggest that Vaxart's shares are less volatile than average (for this exchange).
Vaxart, Inc. , a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase II clinical trial with bivalent oral tablet vaccine for the GI. 1 and GII. 4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine, an oral vaccine platform, which is in preclinical stage; coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection; human papillomavirus therapeutic vaccine that targets HPV 16 and HPV 18 for cervical cancers and precancerous cervical dysplasia. The company has license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad spectrum antiviral.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…Everything we know about the Neuraxis IPO plus information on how to buy in.
Everything we know about the Brera IPO plus information on how to buy in.
Everything we know about the TXO Energy IPO plus information on how to buy in.
Your guide to how ETFs work and whether this type of investment is right for you.
Steps to owning and managing TXG stock, with 24-hour and historical pricing before you buy.
The best stock trading app for beginners is easy to use and offers free trades.
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
An healthcare company, NFT tech developer and baby products retailer are among the IPOs expected to take place this month.
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
The best time to buy stocks could be right after an IPO, during expansion periods or when other investors are buying or selling.
